Rotavirus spike protein ΔVP8* as a novel carrier protein for conjugate vaccine platform with demonstrated antigenic potential for use as bivalent vaccine.

Differences were considered non-significant (ns) for p-values >0.05 (marked as “ns”), significant for p-values <0.05 (marked as *), highly significant for p-values <0.01 (marked as **) and extremely significant for p-values <0.001 (marked as ***), respectively.

also in 5,970 other papers